Conjugative CRISPR System Cuts Resistance
Mobile gene drive-like platform spreads between bacteria and reduces ampicillin resistance by up to 5 logs while enabling cassette reversal
By
Julie Greenbaum
February 13, 2026
Clinical Scorecard: Conjugative CRISPR System Cuts Resistance
At a Glance
Category Detail
Condition Antibiotic resistance in bacterial populations Key Mechanisms Conjugative transfer of anti-antibiotic resistance cassettes via engineered plasmids and CRISPR-Cas9 mediated deletion Target Population Bacterial strains, particularly those resistant to ampicillin Care Setting Microbiome engineering and environmental remediation
Key Highlights
Reduction of ampicillin-resistant CFU by three to five logs in bacterial populations Enhanced effects observed in RecA-deficient recipient strains Homology-based deletion mechanism identified as a significant method for disrupting antibiotic resistance Pro-AG and homology-based deletion mechanisms can be delivered via plasmids or phages Insertional inactivation shown to be more efficient than plasmid elimination Guideline-Based Recommendations
Diagnosis
Evaluate bacterial resistance profiles using colony-forming unit (CFU) enumeration Management
Utilize engineered plasmids for targeted disruption of antibiotic resistance genes Monitoring & Follow-up
Monitor changes in resistance patterns post-intervention Risks
Potential for uncontrolled spread of gene cassettes if not properly managed Patient & Prescribing Data
Bacterial strains exhibiting antibiotic resistance
Targeted gene editing strategies may restore susceptibility to antibiotics
Clinical Best Practices
Implement conjugative CRISPR systems for effective management of antibiotic resistance Consider the role of RecA in enhancing gene editing outcomes Utilize lambda Red to improve recovery of edited plasmids References
